[1] Chen C,Wang XF,Sun L,et al.Expression of TGF-β type III receptor restores autocrine TGF-β1 activity in human breast cancer MCF-7 cells[J].J Biol Chem,1997,272(19):12862-12867.
[2] Massague J.TGF-β signal transduction[J].Annu Rev Biochem,1998,67:753-791.
[3] Nakao A,Afrakhte M.Identification of Smas7,a TGF-β-inducible an-tagonist of TGF-β signaling[J].Nature,1997,389(6651):631-635.
[4] Mallat Z,Gojova A,Marchiol-Fournigault C,et al.Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice[J].Circ Res,2001,89(10):930-934.
[5] Argmann CA,Van Den Diepstraten CH,Sawyez CG,et al.Transforming growth factor-β1 inhibits macrophage cholesteryl ester accumulation induced by native and ox-idized V L D L remnants[J].Ar-terioscler Throm Vasc Biol,2001,21(12):2011-2018.
[6] Zuckerman SH,Panousis C,Evans G.TGF-beta reduced binding of high-density lipoproteins in murine macrophages and macrophage-derived foam cells[J].Atherosclerosis,2001,155(1):79-85.
[7] Minami M,Kume N,Kataoka H,et al.Transforming growth factor-beta(1) increases the expression of lectin-like oxidized low-density lipoprotein receptor-1[J].Biochem Biophys Res Commun,2000,272(2):357-361.
[8] Oemar BS,Werner A,Garnier JM,et al.Human connective tissue growth factorIs expressedin advanced atherosclerotic lesions[J].Circulation,1997,95(4):831-839.
[9] Tashiro H,Shimokawa H,Sadamatu K,et al.Prognostic significance of plasma concentrations of transforming growth factor-beta in patients with coronary artery disease[J].Coron Artery Dis,2002,13(3):139-143.
[10] Feinberg M W,Jain MK,Werner F,et al.Transforming growth factor-beta 1 inhibits cytokine-mediated induction of human metalloelastase in macrophages[J].J Biol Chem,2000,275(33):25766-25773.
[11] Leiro JM,Alvarez E,Arranz JA,et al.In vitro effects of mangiferin on superoxide concentrations and expression of the inducible nitric oxide synthase,tumour necrosis factor-alpha and transforming growth factor-beta genes[J].Biochem Pharmacol,2003,65(8):1361-1371.
[12] Porreca E,Di-Febbo C,Baccante G,et al.Increased transforminggrowth factor-beta (1) circulating levels and production in human monocytes after 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibition with pravastatin[J].J Am Coll Cardiol,2002,39(11):1752-1757.
[13] Febbraio M,Guy E,Coburn C,et al.The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36[J].Mol Cell Biochem,2002,239(1-2):193-197.
[14] Tsukazali T,Chiang TA,Davison AF,et al.SARA,a FYVE domain protein that recruits Smad2 to the TGFβ receptor[J].Cell,1998,95(6):779-791.
[15] Gojova A,Brun V,Esposito B,et al.Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and compositionin mice[J].Blood,2003,102(12):4052-4058.
[16] Chen X,Ren S,M a M G,et al.Hirulog-like peptide reduces restenosis and expression of tissue factor and transforming growth factor-beta in carotid artery of atherosclerotic rabbits[J].Atherosclerosis,2003,169(1):31-40.
[17] Kintscher U,Lyon C,Wakino S,et al.PPARalpha inhibits TGF-beta-induced beta5 integrin transcription in vascular smooth muscle cells by interacting with Smad4[J].Circ Res,2002,91(11):e35-e44.
[18] Su JZ,Fukuda N,Hu WY,et al.Ribozyme to human TGF-betal mRNA inhibits the proliferation of human vascular smooth muscle cells[J].Biochem Biophys Res Commun,2000,278(2):401-407.
[19] Yamamoto K,Morishita R,Tomita N,et al.Ribozyme oligonucleotides against transforming growth factor-beta inhibited neointi-mal formation after vascular injury in rat model:potential application of ribozyme strategy to treat cardiovascular disease[J].Circu-lation,2000,102(11):1308-1314.
[20] Saiura A,Sata M,Hirata Y,et al.Tranilast inhibits transplant-associated coronary arteriosclerosis in a murine model of cardiac transplantation[J].Eur J Pharmacol,2001,433(2-3):163-168.